Abstract

Keloids and hypertrophic scars are caused by cutaneous injury and irritation, including trauma, insect bite, burn, surgery, vaccination, skin piercing, acne, folliculitis, chicken pox, and herpes zoster infection. Notably, superficial injuries that do not reach the reticular dermis never cause keloidal and hypertrophic scarring. This suggests that these pathological scars are due to injury to this skin layer and the subsequent aberrant wound healing therein. The latter is characterized by continuous and histologically localized inflammation. As a result, the reticular layer of keloids and hypertrophic scars contains inflammatory cells, increased numbers of fibroblasts, newly formed blood vessels, and collagen deposits. Moreover, proinflammatory factors, such as interleukin (IL)-1α, IL-1β, IL-6, and tumor necrosis factor-α are upregulated in keloid tissues, which suggests that, in patients with keloids, proinflammatory genes in the skin are sensitive to trauma. This may promote chronic inflammation, which in turn may cause the invasive growth of keloids. In addition, the upregulation of proinflammatory factors in pathological scars suggests that, rather than being skin tumors, keloids and hypertrophic scars are inflammatory disorders of skin, specifically inflammatory disorders of the reticular dermis. Various external and internal post-wounding stimuli may promote reticular inflammation. The nature of these stimuli most likely shapes the characteristics, quantity, and course of keloids and hypertrophic scars. Specifically, it is likely that the intensity, frequency, and duration of these stimuli determine how quickly the scars appear, the direction and speed of growth, and the intensity of symptoms. These proinflammatory stimuli include a variety of local, systemic, and genetic factors. These observations together suggest that the clinical differences between keloids and hypertrophic scars merely reflect differences in the intensity, frequency, and duration of the inflammation of the reticular dermis. At present, physicians cannot (or at least find it very difficult to) control systemic and genetic risk factors of keloids and hypertrophic scars. However, they can use a number of treatment modalities that all, interestingly, act by reducing inflammation. They include corticosteroid injection/tape/ointment, radiotherapy, cryotherapy, compression therapy, stabilization therapy, 5-fluorouracil (5-FU) therapy, and surgical methods that reduce skin tension.

Highlights

  • Keloids and hypertrophic scars are caused by cutaneous injury and irritation, including trauma, insect bite, burn, surgery, vaccination, skin piercing, acne, folliculitis, chicken pox, and herpes zoster infection

  • While keloids and hypertrophic scars are generally first observed around 3 months after injury, this merely reflects the fact that the inflammation of the reticular dermis, which starts immediately after the initial injury, only becomes visible through the epidermis to the naked eye at this time point

  • This is supported by our unpublished data, which suggest that the incidence of keloids that are not caused by trauma suddenly increases at around 10 years of age

Read more

Summary

Introduction

Keloids and hypertrophic scars are caused by cutaneous injury and irritation, including trauma, insect bite, burn, surgery, vaccination, skin piercing, acne, folliculitis, chicken pox, and herpes zoster infection. In the case of surgical wounds, both patients and physicians tend to believe (erroneously) that the sutured wound has matured when the sutures are removed This is because at this point (i.e., 7–14 days after surgery), the epidermis has regenerated and the wound is closed and dry. At this stage, the dermal matrix is still maturing and there is ongoing inflammation in the reticular dermis If, at this time point, the reticular layer is subjected to external and/or internal stimulation, the inflammation fails to subside and instead becomes increasingly pronounced. At this time point, the reticular layer is subjected to external and/or internal stimulation, the inflammation fails to subside and instead becomes increasingly pronounced This yields pathological scars that eventually become apparent a few months after surgery. We define “keloid” as strongly inflamed pathological scars while “hypertrophic scars” are defined as weakly inflamed pathological scars

Local Risk Factors That Increase Dermal Inflammation
Systemic Risk Factors That Increase Dermal Inflammation
Genetic Risk Factors That Increase Dermal Inflammation
Histopathology and Genetic Analysis of Keloid Tissue
Treatment of Keloids and Hypertrophic Scars
Surgery
Findings
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.